Login to Your Account



Other News To Note


Tuesday, August 2, 2011
Stealth Peptides Inc., of Boston, reported it presented data from animal studies of lead candidate Bendavia, for treatment of mitochondrial dysfunction including ischemia reperfusion and microvascular injuries, during the 2011 American Heart Association's Cardiovascular Scientific Sessions in New Orleans.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription